Hillmer AM, Brockschmidt FF, Hanneken S, Eigelshoven S, Steffens M, Flaquer A, Herms S, Becker T, Kortm A-K, Nyholt DR, Zhao ZZ, Montgomery GW, Martin NG, Mhleisen TW, Alblas MA, Moebus S, Jckel K-H, Brcker-Preuss M, Erbel R, Reinartz R, Betz RC, Cichon S, Propping P, Baur MP, Wienker TF, Kruse R, Nthen MM
Hulu delved into the counterfeit GLP-1 market and Fierce Healthcare covered AFPs
"SIGNET PLANS CREDIT CARD UNIT SPINOFF"
India: India is one of the fastest-growing clinical trials market, driven by its diverse population, increasing healthcare awareness, and cost-effective trial execution
Immuno-detection of OCTN1 (SLC22A4) in HeLa cells and characterization of transport function
Medicare Advantage plans maintain formularies separate from commercial HMO and PPO products, so a medication may appear on one and not the other